| 000 | 01713 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517185746.0 | ||
| 264 | 0 | _c20180629 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1475-2875 | ||
| 024 | 7 |
_a10.1186/s12936-017-2128-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBonnington, Craig A | |
| 245 | 0 | 0 |
_aPlasmodium falciparum Kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin State, Myanmar. _h[electronic resource] |
| 260 |
_bMalaria journal _c11 2017 |
||
| 300 |
_a480 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntimalarials _xtherapeutic use |
| 650 | 0 | 4 |
_aArtemisinins _xtherapeutic use |
| 650 | 0 | 4 | _aArtesunate |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aMalaria, Falciparum _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aMyanmar |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPlasmodium falciparum _xdrug effects |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aProtozoan Proteins _xgenetics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aPhyo, Aung Pyae | |
| 700 | 1 | _aAshley, Elizabeth A | |
| 700 | 1 | _aImwong, Mallika | |
| 700 | 1 | _aSriprawat, Kanlaya | |
| 700 | 1 | _aParker, Daniel M | |
| 700 | 1 | _aProux, Stephane | |
| 700 | 1 | _aWhite, Nicholas J | |
| 700 | 1 | _aNosten, Francois | |
| 773 | 0 |
_tMalaria journal _gvol. 16 _gno. 1 _gp. 480 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12936-017-2128-x _zAvailable from publisher's website |
| 999 |
_c27828568 _d27828568 |
||